Stocks to sell

BlackBerry (NYSE:BB) stock often rises meteorically and then crashes quickly. That’s what has happened recently to the shares of the Canadian company that was once known for its phones and is now focused on security software.  Source: Paul McKinnon/Shutterstock.com BB stock doubled between June 1 and June 3, spiking above $20 at 9:30 am on
0 Comments
Just when I thought there might be a nice orderly selloff of GameStop (NYSE:GME) stock, the Reddit crowd is back at it. In the 30 days ending June 1, GME stock jumped 53%. And the only explanation that seems to fit is that the Reddit crowd simply loves to pump up heavily shorted stocks.   Source: Shutterstock
0 Comments
Hopeful investors gave up in the weeks that followed QuantumScape’s (NYSE:QS) quarterly results. QS stock tried to bounce back to above the $30 range last month but failed. Source: Michael Vi/Shutterstock.com Investors cannot get over the higher capital expenses ahead. Though liquidity fueled the stock after its post-SPAC (special purpose acquisition company) status, reality weighs
0 Comments
With Airbnb (NASDAQ:ABNB) unlikely to benefit from the reopening of economies as much as conventional hotels and still facing multiple other challenges, I continue to recommend selling ABNB stock. Source: BigTunaOnline / Shutterstock.com Further, the shares’ extremely high valuation compared to other names in the lodging sector makes me wary of recommending the name at
0 Comments
Just because the business of AMC Entertainment (NYSE:AMC) remains fundamentally unchanged doesn’t mean that AMC stock should stagnate. That much was proven to be true on May 28, when the “meme stock” rocketed upward again, reaching a high of $36.72. Source: rblfmr / Shutterstock.com However, this particular run up in AMC stock was fundamentally different
0 Comments
After investigating Palantir (NYSE:PLTR) further, I’ve found more reasons to be worried about PLTR stock. Despite the company’s large year-over-year (YOY) growth rates in the first quarter, there are signs that Palantir’s top-line expansion is stagnating. Its net losses rapidly increased on a YOY basis last quarter and in all of 2020. Source: Sundry Photography
0 Comments
Since the start of May, Covid-19 vaccine play Ocugen (NASDAQ:OCGN) stock is down around 50%. But the company has made some progress in bringing Covaxin, developed in India by Bharat Biotech, to the U.S. market. So, are things back on track? Source: Shutterstock Yes and no. Sure, the company now has a set date (June)
0 Comments